9 employees
Lys Therapeutics develops drugs to treat patients suffering from neurovascular or neurodegenerative disorders.
2021
$3.1M
from 1 investors over 1 rounds
Lys Therapeutics raised $3.1M on November 14, 2022
Investors: HTH - Health Technologies Holding